Clinical Trial Update: Study of Everolimus (RAD001) in Combination With Lenalidomide [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating everolimus in combination with lenalidomide for solid organ malignancies and adenoid cystic carcinoma has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Neuroendocrine Tumors
• Solid Organ Malignancies

Drugs mentioned

• Everolimus (everolimus)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Emory University | Conditions: Solid Organ Malignancies, Adenoidcystic Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2022-01-27